Red Cell Exchange with a Targeted Ht of 34% in Sickle Cell Disease: A Cohort Study from CHUM

Red Cell Exchange with a Targeted Ht of 34% in Sickle Cell Disease: A Cohort Study from CHUM

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2022-11, Vol.140 (Supplement 1), p.2574-2575
Hauptverfasser: Mercier-Ross, Jules, Lemay, Anne-Sophie, Forté, Stéphanie, Rioux-Massé, Benjamin, Mercure-Corriveau, Nicolas, Soulières, Denis
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2575
container_issue Supplement 1
container_start_page 2574
container_title Blood
container_volume 140
creator Mercier-Ross, Jules
Lemay, Anne-Sophie
Forté, Stéphanie
Rioux-Massé, Benjamin
Mercure-Corriveau, Nicolas
Soulières, Denis
description
doi_str_mv 10.1182/blood-2022-168328
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_168328</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122026234</els_id><sourcerecordid>S0006497122026234</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1378-c3017ef08f977ea014fd3f1680e62afb1f139ce59fdf790bbb30474ee3fd6ca3</originalsourceid><addsrcrecordid>eNp9kD1PwzAURS0EEqXwA9i8MAae7TQfMFWhUKQiJFo2JMuxn1tDWiM7BfrvSQkz0x2eztO9h5BzBpeMFfyqbrw3CQfOE5YVghcHZMBGvEgAOBySAQBkSVrm7JicxPgGwFLBRwPy-oyGVtg0dPKtV2qzRPrl2hVVdKHCEtvuOm2pt1SkF9Rt6Nzp9wZ74tZFVBGv6ZhWfuVDS-ft1uyoDX5Nq-nL4yk5sqqJePaXQ7K4myyqaTJ7un-oxrNEM5EXiRbAcrRQ2DLPUXXVrBG2mwGYcWVrZpkoNY5Ka2xeQl3XAtI8RRTWZFqJIWH9Wx18jAGt_AhurcJOMpB7O_LXjtzbkb2djrnpGex6fToMMmqHG43GBdStNN79Q_8AxwprNA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Red Cell Exchange with a Targeted Ht of 34% in Sickle Cell Disease: A Cohort Study from CHUM</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Mercier-Ross, Jules ; Lemay, Anne-Sophie ; Forté, Stéphanie ; Rioux-Massé, Benjamin ; Mercure-Corriveau, Nicolas ; Soulières, Denis</creator><creatorcontrib>Mercier-Ross, Jules ; Lemay, Anne-Sophie ; Forté, Stéphanie ; Rioux-Massé, Benjamin ; Mercure-Corriveau, Nicolas ; Soulières, Denis</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-168328</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.2574-2575</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Mercier-Ross, Jules</creatorcontrib><creatorcontrib>Lemay, Anne-Sophie</creatorcontrib><creatorcontrib>Forté, Stéphanie</creatorcontrib><creatorcontrib>Rioux-Massé, Benjamin</creatorcontrib><creatorcontrib>Mercure-Corriveau, Nicolas</creatorcontrib><creatorcontrib>Soulières, Denis</creatorcontrib><title>Red Cell Exchange with a Targeted Ht of 34% in Sickle Cell Disease: A Cohort Study from CHUM</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kD1PwzAURS0EEqXwA9i8MAae7TQfMFWhUKQiJFo2JMuxn1tDWiM7BfrvSQkz0x2eztO9h5BzBpeMFfyqbrw3CQfOE5YVghcHZMBGvEgAOBySAQBkSVrm7JicxPgGwFLBRwPy-oyGVtg0dPKtV2qzRPrl2hVVdKHCEtvuOm2pt1SkF9Rt6Nzp9wZ74tZFVBGv6ZhWfuVDS-ft1uyoDX5Nq-nL4yk5sqqJePaXQ7K4myyqaTJ7un-oxrNEM5EXiRbAcrRQ2DLPUXXVrBG2mwGYcWVrZpkoNY5Ka2xeQl3XAtI8RRTWZFqJIWH9Wx18jAGt_AhurcJOMpB7O_LXjtzbkb2djrnpGex6fToMMmqHG43GBdStNN79Q_8AxwprNA</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Mercier-Ross, Jules</creator><creator>Lemay, Anne-Sophie</creator><creator>Forté, Stéphanie</creator><creator>Rioux-Massé, Benjamin</creator><creator>Mercure-Corriveau, Nicolas</creator><creator>Soulières, Denis</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>Red Cell Exchange with a Targeted Ht of 34% in Sickle Cell Disease: A Cohort Study from CHUM</title><author>Mercier-Ross, Jules ; Lemay, Anne-Sophie ; Forté, Stéphanie ; Rioux-Massé, Benjamin ; Mercure-Corriveau, Nicolas ; Soulières, Denis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1378-c3017ef08f977ea014fd3f1680e62afb1f139ce59fdf790bbb30474ee3fd6ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mercier-Ross, Jules</creatorcontrib><creatorcontrib>Lemay, Anne-Sophie</creatorcontrib><creatorcontrib>Forté, Stéphanie</creatorcontrib><creatorcontrib>Rioux-Massé, Benjamin</creatorcontrib><creatorcontrib>Mercure-Corriveau, Nicolas</creatorcontrib><creatorcontrib>Soulières, Denis</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mercier-Ross, Jules</au><au>Lemay, Anne-Sophie</au><au>Forté, Stéphanie</au><au>Rioux-Massé, Benjamin</au><au>Mercure-Corriveau, Nicolas</au><au>Soulières, Denis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Red Cell Exchange with a Targeted Ht of 34% in Sickle Cell Disease: A Cohort Study from CHUM</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>2574</spage><epage>2575</epage><pages>2574-2575</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-168328</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2022-11, Vol.140 (Supplement 1), p.2574-2575
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_2022_168328
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title Red Cell Exchange with a Targeted Ht of 34% in Sickle Cell Disease: A Cohort Study from CHUM
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T07%3A05%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Red%20Cell%20Exchange%20with%20a%20Targeted%20Ht%20of%2034%25%20in%20Sickle%20Cell%20Disease:%20A%20Cohort%20Study%20from%20CHUM&rft.jtitle=Blood&rft.au=Mercier-Ross,%20Jules&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=2574&rft.epage=2575&rft.pages=2574-2575&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-168328&rft_dat=%3Celsevier_cross%3ES0006497122026234%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122026234&rfr_iscdi=true